Hanna-Maaria Lakka

Hanna-Maaria Lakka

Auto-generated profile, based on publicly available information

Hanna-Maaria Lakka

Pennington Biomedical Research Center, Louisiana State University, 6400 Perkins Road, Baton Rouge, Louisiana 70808-4124, USA

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2002 in JAMA
Verified
Journal Article
Open access
PDF file
HLHanna-Maaria Lakka
Hanna-Maaria Lakka
DLDavid E. Laaksonen
David E. Laaksonen
TLTimo Lakka
Timo Lakka
LNLeo K. Niskanen
Leo K. Niskanen
EKEsko Kumpusalo
Esko Kumpusalo
JSJukka T. Salonen
Jukka T. Salonen
The metabolic syndrome, a concurrence of disturbed glucose and insulin metabolism, overweight and abdominal fat distribution, mild dyslipidemia, and hypertension, is most important because of its association with subsequent development of type 2 diabetes mellitus and cardiovascular disease (CVD).1,2 The syndrome is characterized by insulin resistance and is also known as the insulin resistance syndrome. The pathogenesis of the syndrome has multiple origins, but obesity and sedentary lifestyle coupled with diet and still largely unknown genetic factors clearly interact to produce the syndrome.1-3

1 September 2002 in Hormone and Metabolic Research
Verified
Journal Article
Closed access
PDF file
HLH.-M. Lakka
H.-M. Lakka
JSJ. T. Salonen
J. T. Salonen
JTJ. Tuomilehto
J. Tuomilehto
GKG. A. Kaplan
G. A. Kaplan
TLTimo Lakka
Timo Lakka
We investigated the temporal relationships between obesity, weight change and hyperinsulinemia in a population-based 4-year follow-up study of 695 middle-aged, non-diabetic, and normoinsulinemic men. Thirty-eight men developed hyperinsulinemia during the follow-up (fasting serum insulin ≥ 12.0 mU/l). In logistic regression analysis adjusting for other risk factors, men with body mass index of ≥ 26.7 kg/m2 (highest third) had a 6.6-fold (p = 0.001) risk of developing hyperinsulinemia, compared with men with body mass index of < 24.4 kg/m2 (lowest third). Correspondingly, men with waist-to-hip ratio of ≥ 0.95 (highest third) had a 3.5-fold (p = 0.028) incidence of hyperinsulinemia compared with men with waist-to-hip ratio of < 0.90 (lowest third). Weight gain in middle age and weight gain from the age of 20 years to middle age were also associated with increased risk of hyperinsulinemia. Hyperinsulinemia at baseline was not associated with weight gain during the follow-up. This prospective population-based study emphasizes the importance of avoiding obesity and weight gain during adulthood in preventing hyperinsulinemia.

1 May 2006 in Vascular Pharmacology
Verified
Journal Article
Closed access
HLHanna-Maaria Lakka
Hanna-Maaria Lakka
TLTimo Lakka
Timo Lakka
TRTuomo Rankinen
Tuomo Rankinen
TRTreva Rice
Treva Rice
DRD.C. Rao
D.C. Rao
CBClaude Bouchard
Claude Bouchard